Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.

Baird RD, van Rossum AGJ, Oliveira M, Beelen K, Gao M, Schrier M, Mandjes IAM, Garcia-Corbacho J, Vallier AL, Dougall G, van Werkhoven E, Linossi C, Kumar S, van Tinteren H, Callari M, Beddowes E, Perez-Garcia JM, Rosing H, Platte E, Nederlof P, Schot M, de Vries Schultink A, Bernards R, Saura C, Gallagher W, Cortès J, Caldas C, Linn SC.

Clin Cancer Res. 2019 Nov 15;25(22):6598-6605. doi: 10.1158/1078-0432.CCR-19-0508. Epub 2019 Aug 22.

PMID:
31439579
2.

A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX).

Bex A, van Thienen JV, Schrier M, Graafland N, Kuusk T, Hendricksen K, Lagerveld B, Zondervan P, van Moorselaar JA, Blank C, Wilgenhof S, Haanen J.

Future Oncol. 2019 Jul;15(19):2203-2209. doi: 10.2217/fon-2019-0111. Epub 2019 Apr 26. Erratum in: Future Oncol. 2019 Aug;15(22):2667.

PMID:
31023100
3.

Intimate Partner Violence Screening and Counseling: An Introductory Session for Health Care Professionals.

Schrier MW, Rougas SC, Schrier EW, Elisseou S, Warrie S.

MedEdPORTAL. 2017 Sep 5;13:10622. doi: 10.15766/mep_2374-8265.10622.

4.

Assessing acceptability and feasibility of provider-initiated HIV testing and counseling in Ghana.

Tabb Z, Moriarty K, Schrier MW, Amekah E, Flanigan TP, Lartey M.

R I Med J (2013). 2017 Aug 1;100(8):19-22.

PMID:
28759895
5.

Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4.

Schrier MS, Trivedi MS, Deth RC.

Front Oncol. 2017 Mar 30;7:46. doi: 10.3389/fonc.2017.00046. eCollection 2017.

6.

A Cautionary Tale About a Bridesmaid's DRESS.

Schrier MW, Alverson B.

Hosp Pediatr. 2016 Aug;6(8):501-3. doi: 10.1542/hpeds.2015-0287. No abstract available.

7.

E2F mediates enhanced alternative polyadenylation in proliferation.

Elkon R, Drost J, van Haaften G, Jenal M, Schrier M, Oude Vrielink JA, Agami R.

Genome Biol. 2012 Jul 2;13(7):R59. doi: 10.1186/gb-2012-13-7-r59.

8.

Association of fibromyalgia characteristics in patients with non-metastatic breast cancer and the protective role of resilience.

Schrier M, Amital D, Arnson Y, Rubinow A, Altaman A, Nissenabaum B, Amital H.

Rheumatol Int. 2012 Oct;32(10):3017-23. Epub 2011 Sep 8.

PMID:
21901352
9.

Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies.

Liu X, Hairston J, Schrier M, Fan J.

Neurosci Biobehav Rev. 2011 Apr;35(5):1219-36. doi: 10.1016/j.neubiorev.2010.12.012. Epub 2010 Dec 24. Review.

10.

miR-148 targets human DNMT3b protein coding region.

Duursma AM, Kedde M, Schrier M, le Sage C, Agami R.

RNA. 2008 May;14(5):872-7. doi: 10.1261/rna.972008. Epub 2008 Mar 26.

11.

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.

Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Puré E, Agami R.

Nat Cell Biol. 2008 Feb;10(2):202-10. doi: 10.1038/ncb1681. Epub 2008 Jan 13.

PMID:
18193036
12.

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R.

Adv Exp Med Biol. 2007;604:17-46.

PMID:
17695719
13.

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA, Farace MG, Agami R.

EMBO J. 2007 Aug 8;26(15):3699-708. Epub 2007 Jul 12.

14.

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R.

Cell. 2006 Mar 24;124(6):1169-81.

15.

Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.

Schrier M, Severijnen LA, Reis S, Rife M, van't Padje S, van Cappellen G, Oostra BA, Willemsen R.

Exp Neurol. 2004 Oct;189(2):343-53.

PMID:
15380484
16.

The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen LA, Nieuwenhuizen IM, Schrier M, van Unen L, Tassone F, Hoogeveen AT, Hagerman PJ, Mientjes EJ, Oostra BA.

Hum Mol Genet. 2003 May 1;12(9):949-59.

PMID:
12700164
17.

Transport of fragile X mental retardation protein via granules in neurites of PC12 cells.

De Diego Otero Y, Severijnen LA, van Cappellen G, Schrier M, Oostra B, Willemsen R.

Mol Cell Biol. 2002 Dec;22(23):8332-41.

18.

Contamination in the Rare-Earth Element Orthophosphate Reference Samples.

Donovan JJ, Hanchar JM, Picolli PM, Schrier MD, Boatner LA, Jarosewich E.

J Res Natl Inst Stand Technol. 2002 Dec 1;107(6):693-701. doi: 10.6028/jres.107.056. Print 2002 Nov-Dec.

19.

Enthalpies of transfer for proteins from aqueous to water-alcohol solutions: a test for models of residues exposed to solvent.

Schrier MY, Defoster G, Schrier EE, Starzak M.

Biopolymers. 1986 Jan;25(1):119-34. No abstract available.

PMID:
3947717
20.
21.

The eye that wouldn't quit.

Schrier M.

J Am Optom Assoc. 1976 Apr;47(4):539. No abstract available.

PMID:
1027857
22.

The $10,000 fee--almost.

Schrier M.

J Am Optom Assoc. 1976 Apr;47(4):538. No abstract available.

PMID:
1027856
23.

Letter: Thermography in venous thrombosis.

Franco JA, Kovaleski B, Vanags K, Schrier M.

West J Med. 1974 May;120(5):419-20. No abstract available.

24.

Freshman visual screening program at Columbia University.

SCHRIER M.

Am J Optom Arch Am Acad Optom. 1960 May;37:244-53. No abstract available.

PMID:
14443590

Supplemental Content

Loading ...
Support Center